The novel therapy of this peptide represents a significant development in the handling of diabetes mellitus type 2. Unlike existing medications, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide508183.actoblog.com/42967524/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment